BARRONESS LIMITED
Company number 14760715 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
BARRONESS LIMITED - Analysis Report
Company Number: 14760715
Analysis Date: 2025-07-19 12:05 UTC
Financial Health Assessment of Barroness Limited
1. Financial Health Score: B
Explanation:
Barroness Limited exhibits a solid financial foundation for a newly incorporated micro entity. The company shows positive net current assets and net assets, indicating a healthy liquidity position and a positive equity base. However, as a start-up with limited operational history and no employees, there is a degree of caution warranted until consistent trading results and cash flow patterns emerge. The "B" grade reflects a financially stable but early-stage company with potential to strengthen further.
2. Key Vital Signs
| Metric | Value (£) | Interpretation |
|---|---|---|
| Fixed Assets | 1,001 | Minimal investment in long-term assets, typical for a micro entity in publishing. |
| Current Assets | 41,462 | Healthy level of short-term assets, likely cash or receivables, supporting operational liquidity. |
| Current Liabilities | 19,927 | Short-term obligations are moderate; manageable given current assets. |
| Net Current Assets | 21,535 | Positive working capital indicates the company can cover short-term debts comfortably. |
| Total Assets Less Current Liabilities | 22,536 | Reflects net asset base after deducting current liabilities, a positive sign of solvency. |
| Net Assets/Shareholders’ Funds | 19,951 | Equity base shows owner’s investment and retained earnings; positive net worth. |
| Employees | 0 | No employees reported, indicating low overhead but possibly limited operational scale. |
Interpretation:
The company’s liquidity is "healthy cash flow" territory at this stage, with net current assets more than covering current liabilities. Positive net assets and shareholders’ funds show the company is solvent and funded adequately for its size. The absence of employees suggests low fixed costs but also that the business activity may be limited or reliant on the director’s own input.
3. Diagnosis
Barroness Limited is in the nascent stage of its lifecycle, having been incorporated in March 2023 and filing its first micro-entity accounts for a 14-month period ending May 2024. The financial "vital signs" present no immediate symptoms of distress such as negative working capital or net liabilities. The company has effectively matched its current liabilities with sufficient current assets, indicating no immediate liquidity crunch.
However, the minimal fixed asset base and no employees indicate a lean operation, likely reliant on the director’s own expertise and possibly outsourcing or non-employee contractors. This means the company’s financial health depends heavily on the director’s ability to generate revenue and manage cash flow prudently.
Given the early stage and micro category, the absence of audit requirements reduces administrative burden but also means less external scrutiny—business owners should maintain rigorous internal controls.
4. Recommendations
- Cash Flow Monitoring: Maintain vigilant monitoring of cash inflows and outflows to ensure ongoing "healthy cash flow," particularly as operational activities expand.
- Revenue Diversification: Explore avenues to grow revenue streams to build resilience beyond sole reliance on the director’s input.
- Build Working Capital Cushion: Aim to increase net current assets further to buffer against unforeseen expenses or delayed receivables.
- Consider Employment Needs: As the business scales, evaluate the need for staff to support operations, balancing increased overhead against growth benefits.
- Regular Financial Reviews: Schedule quarterly financial health checks to catch any early warning signs of liquidity or solvency issues.
- Compliance & Governance: Stay current with filing deadlines and maintain compliance documentation to avoid penalties or reputational risks.
- Strategic Planning: Develop a medium-term plan outlining growth targets, capital requirements, and risk management to guide decision-making.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.